🟢 Eupraxia Pharmaceuticals is trading 5% up in after-hours trading; catalyst unconfirmed

Eupraxia Pharmaceuticals is trading 5.07% up at $8.50 after closing at $8.09 on September 16, 2026; the catalyst remains unconfirmed.

• Recent investor-conference appearances occurred on September 15–16, including Morgan Stanley’s healthcare conference.
• No new company-specific announcement clearly explains the after-hours move, and broader market signals were mixed.